What Details? A Lack of Transparency Impedes Access to Medicines
The lack of affordable prescription medicines is a global problem. But even as various governments, nonprofit organizations and pharmaceutical companies attempt to address the issue, agreements lack transparency. The absence of key details - notably, pricing, in some instances - makes it difficult to determine whether the deals will sufficiently succeed in providing needed medicines.
Authors
- Ed Silverman
Publication Details
- Journal
- The Journal of Law Medicine & Ethics
- Published
- 2026-11-06
- DOI
- https://doi.org/10.1017/jme.2026.10300
- Primary Topic
- Pharmaceutical Economics and Policy
- Type
- article
- Field-Weighted Citation Impact
- 0.00